← Open Payments lookup

ALISON KRASKA: Open Payments

NPI 1801652342 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,555 in 114 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $889 · 2025 $2,555

Food & beverage: $2,555
CompanyPaymentsAmount
ABBVIE INC.19$655
Otsuka America Pharmaceutical, Inc.19$254
Neurocrine BioSciences, Inc.10$221
E.R. Squibb & Sons, L.L.C.10$180
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$179
Alkermes, Inc.8$152
Vanda Pharmaceuticals Inc.6$147
Axsome Therapeutics, Inc.8$147
Takeda Pharmaceuticals U.S.A., Inc.5$125
Janssen Pharmaceuticals, Inc4$122

Products named: VRAYLAR, INGREZZA, REXULTI, COBENFY, CAPLYTA, FANAPT, ARISTADA, TRINTELLIX.

Industry payments across CT — which companies pay providers there.